OssDsign AB
STO:OSSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (7.1), the stock would be worth kr18.17 (308% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.7 | kr4.45 |
0%
|
| 3-Year Average | 7.1 | kr18.17 |
+308%
|
| 5-Year Average | 7.5 | kr19.16 |
+331%
|
| Industry Average | 3.9 | kr10.02 |
+125%
|
| Country Average | 5.6 | kr14.39 |
+223%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
O
|
OssDsign AB
STO:OSSD
|
492.3m SEK | 1.7 | -9.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 11.8 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29B CHF | 6.6 | 36.4 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
92B DKK | 5.8 | 22.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 4.2 | 31 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 5 | 31.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.1B CNY | 11.8 | 23.7 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 9.5 | 51.2 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | 301.3 | -37.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 3.3 | -15 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 3.3 |
| Median | 5.6 |
| 70th Percentile | 9.2 |
| Max | 18 023.5 |
Other Multiples
OssDsign AB
Glance View
OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
